Stock 2509 QYUNS THERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Qyuns Therapeutics Co., Ltd.

Equities

2509

CNE1000069W9

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:03 23/05/2024 pm IST 		5-day change 1st Jan Change
27.5 HKD -3.34% Intraday chart for Qyuns Therapeutics Co., Ltd. -5.82% 0.00%
10/05 China Grants Investigational New Drug Status to Qyuns Therapeutics' Urticaria Treatment MT
09/05 Qyuns Therapeutics Co., Ltd. Obtains IND Clearance for QX013N for Treatment of Chronic Spontane Urticaria in China CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 21.35 9.662 14.75
EBITDA 1 -155.6 -295.5 -484.1
EBIT 1 -179.3 -324.2 -514.2
Operating Margin -840.05% -3,354.95% -3,486.18%
Earnings before Tax (EBT) 1 -426.5 -312.4 -521.3
Net income 1 -411 -298.2 -507.7
Net margin -1,925.33% -3,086.22% -3,442.13%
EPS 2 -2.566 -1.677 -2.469
Free Cash Flow - -152.5 -125.3
FCF margin - -1,578.81% -849.35%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 11/03/24 11/03/24 26/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 330 319 31.2
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -153 -125
ROE (net income / shareholders' equity) - -45.7% -108%
ROA (Net income/ Total Assets) - -19.3% -35.1%
Assets 1 - 1,547 1,446
Book Value Per Share 2 4.030 3.550 1.400
Cash Flow per Share 2 1.310 1.180 1.030
Capex 1 58 20.1 7.87
Capex / Sales 271.56% 208.18% 53.38%
Announcement Date 11/03/24 11/03/24 26/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
QYUNS THERAPEUTICS CO., LTD. Stock Qyuns Therapeutics Co., Ltd.
0.00% 809M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+10.79% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.65% 106B
BIONTECH SE Stock BioNTech SE
-6.20% 24.69B
ARGENX SE Stock argenx SE
-2.33% 21.97B
GENMAB A/S Stock Genmab A/S
-6.03% 19.27B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.41% 17.56B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-40.50% 17.32B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.64% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+31.84% 12.13B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2509 Stock
  4. Financials Qyuns Therapeutics Co., Ltd.